Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation

Cerebrovascular Diseases

Volumn 32, Issue 4, 2011, Pages 401-405

  Campbell, Bruce C V ^a,b   Costello, Craig ^a   Christensen, Søren ^b   Ebinger, Martin ^d   Parsons, Mark W ^c   Desmond, Patricia M ^b   Barber, P Alan ^e   Butcher, Kenneth S ^f   Levi, Christopher R ^c   De Silva, Deidre A ^g   Lansberg, Maarten G ^h   Mlynash, Michael ^h   Olivot, Jean Marc ^h   Straka, Matus ^h   Bammer, Roland ^h   Albers, Gregory W ^h   Donnan, Geoffrey A ^a   Davis, Stephen M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f UNIVERSITY OF ALBERTA   (Canada)

^g SINGAPORE GENERAL HOSPITAL   (Singapore)

^h STANFORD UNIVERSITY   (United States)

Author keywords

Fluid attenuated inversion recovery; MRI; Stroke; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; AGED; ARTICLE; BLEEDING; BRAIN BLOOD VOLUME; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; FEMALE; FLUID ATTENUATED INVERSION RECOVERY; HEMATOMA; HUMAN; IMAGING SYSTEM; MALE; PARENCHYMAL HEMATOMA; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE;

AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; CLINICAL TRIALS AS TOPIC; FEMALE; FIBRINOLYTIC AGENTS; HEMATOMA; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 80053480590     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000331467     Document Type: Article

References (16)

1. Thomalla G, Rossbach P, Rosenkranz M, Siemonsen S, Krutzelmann A, Fiehler J, Gerloff C: Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol 2009; 65: 724-732.
2. Aoki J, Kimura K, Iguchi Y, Shibazaki K, Iwanaga T, Watanabe M, Kobayashi K, Sakai K, Sakamoto Y: Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time. Cerebrovasc Dis 2011; 31: 435-441.
3. Cho AH, Sohn SI, Han MK, Lee DH, Kim JS, Choi CG, Sohn CH, Kwon SU, Suh DC, Kim SJ, Bae HJ, Kang DW: Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 2008; 25: 572-579. (Pubitemid 351861477)
4. Barreto AD, Martin-Schild S, Hallevi H, Morales MM, Abraham AT, Gonzales NR, Illoh K, Grotta JC, Savitz SI: Thrombolytic therapy for patients who wake-up with stroke. Stroke 2009; 40: 827-832.
5. Silva GS, Lima FO, Camargo EC, Smith WS, Singhal AB, Greer DM, Ay H, Lev MH, Harris GJ, Halpern EF, Sonni S, Koroshetz W, Furie KL: Wake-up stroke: Clinical and neuroimaging characteristics. Cerebrovasc Dis 2010; 29: 336-342.
6. Ebinger M, Galinovic I, Rozanski M, Brunecker P, Endres M, Fiebach JB: Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: A reliable tissue clock? Stroke 2010; 41: 250-255.
7. Cho AH, Kim JS, Kim SJ, Yun SC, Choi CG, Kim HR, Kwon SU, Lee DH, Kim EK, Suh DC, Kang DW: Focal fluid-attenuated inversion recovery hyperintensity within acute diffusion-weighted imaging lesions is associated with symptomatic intracerebral hemorrhage after thrombolysis. Stroke 2008; 39: 3424-3426.
8. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM: Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): A placebo-controlled randomised trial. Lancet Neurol 2008; 7: 299-309.
9. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP: Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60: 508-517. (Pubitemid 44871793)
10. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G: Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): An observational study. Lancet 2007; 369: 275-282. (Pubitemid 46138121)
11. Campbell BC, Christensen S, Butcher KS, Gordon I, Parsons MW, Desmond PM, Barber PA, Levi CR, Bladin CF, De Silva DA, Donnan GA, Davis SM: Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusionweighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke 2010; 41: 82-88.
12. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T: Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 2008; 63: 52-60. (Pubitemid 351240551)
13. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W: Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-1703.
14. Ebinger M, Ostwaldt AC, Galinovic I, Rozanski M, Brunecker P, Nolte CH, Endres M, Fiebach JB: Clinical and radiological courses do not differ between fluid-attenuated inversion recovery-positive and negative patients with stroke after thrombolysis. Stroke 2010; 41: 1823-1825.
15. Chemmanam T, Campbell BCV, Christensen S, Nagakane Y, Desmond PM, Bladin CF, Parsons MW, Levi CR, Barber PA, Donnan GA, Davis SM: Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology 2010; 75: 1040-1047.
16. Campbell BCV, Purushotham A, Christensen S, Desmond P, Nagakane Y, Parsons MW, Lansberg MG, Mlynash M, Straka M, De Silva DA, Olivot JM, Bammer R, Albers GW, Donnan GA, Davis SM: The infarct core is well represented by the acute diffusion lesion: Sustained reversal is infrequent. J Cereb Blood Flow Metab 2011, E-pub ahead of print.